NCT07052604 Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
| NCT ID | NCT07052604 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier de Saint-Denis |
| Condition | Pneumonia, Ventilator-Associated |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-12-15 |
| Primary Completion | 2025-09-15 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.
Eligibility Criteria
Inclusion Criteria: * Adult patients (age ≥ 18 years) * Hospitalized in Medical Intensive Care Unit between January 1, 2018, and December 31, 2023 * Intubated and mechanically ventilated * Diagnosed with ventilator-associated pneumonia caused by Stenotrophomonas maltophilia Exclusion Criteria: * Patients under 18 years old * Patients who refuse the use of their data for research purposes